MFDS — authorised 27 June 2012
- Marketing authorisation holder: EISAI INC
- Status: likely_approved
🇰🇷 Belviq in South Korea
MFDS authorised Belviq on 27 June 2012
Marketing authorisation
Belviq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Belviq approved in South Korea?
Yes. MFDS authorised it on 27 June 2012.
Who is the marketing authorisation holder for Belviq in South Korea?
EISAI INC holds the South Korean marketing authorisation.